ALDH7A1 and peripheral neuropathy: Koyanagi et al. reported that cilostazol may prevent Schwann cell dedifferentiation by increasing cyclic AMP (adenosine monophosphate) signaling through the inhibition of phosphodiesterase (PDE), indicating its potential to alleviate chemotherapy-induced peripheral neuropathy [60].